Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Why do we need a policy change?

The legislation in place today for regulating in silico products actually predates the existence of these technologies. In order for the in silco market to grow and for research in this field to be encouraged, a policy framework for in silico medicine needs to be developed. Just as the internet has created an urgent need to reform how we think about issues such as data security and IPR, in silico medicine requires we reevaluate our existing health policy structures.

Even the most advanced and predictive model has little value to industry if it cannot be submitted as evidence of the effectiveness or safety of their product:

  • Manufacturers of medical devices who use in silico technologies must be provided with a framework for submitting this data to notified bodies, health authorities and evaluators of health technologies.
  • Similarly for pharmaceuticals, a framework for admissibility of in silico clinical trial data needs to be developed so that we can move from exploratory clinical trials in humans, to a scenario where we seek to confirm what we know from in silico methods.

Incentives in policy need to be provided for industries that pioneer this research which has the potentially to drastically decrease overall research costs and greatly improve patient safety. Providing a system for assessing modelling and simulation data that supplement efficacy or safety data is required to bring healthcare into the digital era.

“If healthcare is to move into the digital era, we need new policies that will enable this transition”

NEWS

News Digital Twins at work: when real life meets virtual intelligence – Milan, 29th of May 2025

Digital Twins at work: when real life meets virtual intelligence – Milan, 29th of May 2025

On May 29th, 2025, our President and Secretary General, Thierry Marchal, and Office Manager, Roberta Maggi, took part in the workshop “Digital Twins at Work: When Real Life Meets Virtual Intelligence” held at the Cascina Triulza Auditorium near Milan and organized by Alessandro Maiocchi from Bracco.

News LifeScience 4EU event in Krakow

LifeScience 4EU event in Krakow

As part of the Polish Presidency of the European Council, Klaster LifeScience Krakow led by …

News Welcome to our new Partner: Sano!

Welcome to our new Partner: Sano!

We are delighted to welcome Sano – Centre for Computational Personalised Medicine as a new Partner of the Avicenna Alliance!

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry